VORICONAZOLE Side Effects

7022651-0 | Pneumothorax, Pulmonary Haemorrhage, Pyrexia, Septic Shock
on Sep 27, 2010 Male patient from KOREA, REPUBLIC OF , 51 years of age, weighting 169.8 lb, was diagnosed with aspergillosis, pneumonia (What is pneumonia?), pyrexia and was treated with Voriconazole (View Usage). Patient experienced the following unwanted or unexpected effects: pneumothorax, pulmonary haemorrhage, pyrexia, septic shock. Voriconazole dosage: 200 Mg, 2x/day. During the same period patient was treated with SYNERCID (Unk) (View Synercid Review and Synercid Label ), RANITIDINE (Unk) (View Ranitidine Review and Ranitidine Label ), SEPTRIN (400 Mg, 1x/day) (View Septrin Review and Septrin Label ), PREDNISOLONE (Unk) (View Prednisolone Review and Prednisolone Label ). Patient was hospitalized.

7022604-2 | Septic Shock
Patient was taking Voriconazole (View Usage). Patient had the following side effects: septic shock on Sep 27, 2010 from KOREA, REPUBLIC OF Additional patient health information: Male patient , 70 years of age, weighting 141.1 lb, was diagnosed with systemic candida, infection prophylaxis and. Voriconazole dosage: 280 Mg, 2x/day. During the same period patient was treated with CITOPCIN (100 Mg, 2x/day) (View Citopcin Review and Citopcin Label ), AMIKIN (Unk, 3x/day) (View Amikin Review and Amikin Label ), ZYVOX (600 Mg, 2x/day) (View Zyvox Review and Zyvox Label ), CEFTAZIDIME (2 G, 3x/day) (View Ceftazidime Review and Ceftazidime Label ), IMIPENEM AND CILASTATIN SODIUM (1000 Mg, 4x/day) (View Imipenem And Cilastatin Sodium Review and Imipenem And Cilastatin Sodium Label ).

7001708-4 | Pneumonitis
Adverse event was reported on Sep 14, 2010 by a Female patient taking Voriconazole (View Usage) (Dosage: 300 Mg, 2x/day) was diagnosed with bronchopulmonary aspergillosis and. Location: SINGAPORE , 45 years of age, weighting 103.6 lb, After Voriconazole was administered, patient had the following side effects: pneumonitis. Patient was hospitalized.

6994572-0 | Granuloma, Hepatorenal Failure, Pyrexia
on Sep 16, 2010 Male patient from UNITED STATES , weighting 83.78 lb, was diagnosed with antifungal prophylaxis and was treated with Voriconazole (View Usage). Patient experienced the following unwanted or unexpected effects: granuloma, hepatorenal failure, pyrexia. Voriconazole dosage: 200mg Bid Po. During the same period patient was treated with CIPRO (View Cipro Review and Cipro Label ), SEPTRA (View Septra Review and Septra Label ).


6988624-9 | Diarrhoea, Hallucination, Nausea, Visual Impairment
on Sep 09, 2009 Female patient from UNITED STATES , 84 years of age, weighting 130.1 lb, was treated with Voriconazole (View Usage). Patient had the following side effects: diarrhoea, hallucination, nausea (What is nausea?), visual impairment. Voriconazole dosage: Oral.

6976631-1 | Septic Shock
Patient was taking Voriconazole (View Usage). After Voriconazole was administered, patient had the following side effects: septic shock on Aug 06, 2010 from KOREA, REPUBLIC OF Additional patient health information: Female patient , weighting 105.6 lb, was diagnosed with fungal infection (What is fungal infection?) and. Voriconazole dosage: 300 Mg, 2x/day.

6942939-9 | Electrocardiogram Qt Prolonged
Adverse event was reported on Aug 25, 2010 by a Female patient taking Voriconazole (View Usage) (Dosage: 40mg Q12h Iv) was diagnosed with intestinal mass, lung infection and. Location: UNITED STATES , weighting 13.23 lb, Patient experienced the following unwanted or unexpected effects: electrocardiogram qt prolonged. During the same period patient was treated with CIPRO (View Cipro Review and Cipro Label ), CLINDAMYCIN (View Clindamycin Review and Clindamycin Label ), METRONIDAZOLE (View Metronidazole Review and Metronidazole Label ), SEPTRA (View Septra Review and Septra Label ), CEFEPIME (View Cefepime Review and Cefepime Label ).

6936253-5 | Acute Myeloid Leukaemia, Hepatotoxicity, Nephropathy Toxic, Pneumonia
on Aug 11, 2010 Male patient from KOREA, REPUBLIC OF , 56 years of age, weighting 172.0 lb, was diagnosed with aspergillosis, pneumonia fungal, pyrexia, pain (What is pain?), angina pectoris, cough, pancytopenia and was treated with Voriconazole (View Usage). Patient had the following side effects: acute myeloid leukaemia, hepatotoxicity, nephropathy toxic, pneumonia (What is pneumonia?). Voriconazole dosage: 300 Mg, 2x/day. During the same period patient was treated with AMPHOTERICIN B (View Amphotericin B Review and Amphotericin B Label ), IMIPENEM (500 Mg, 3x/day) (View Imipenem Review and Imipenem Label ), VANCOMYCIN (1000 Mg, 2x/day) (View Vancomycin Review and Vancomycin Label ), ACETAMINOPHEN (650 Mg, 3x/day) (View Acetaminophen Review and Acetaminophen Label ), NICORANDIL (5 Mg, 2x/day) (View Nicorandil Review and Nicorandil Label ), CODEINE (40 Mg, 3x/day) (View Codeine Review and Codeine Label ), NEUTROGIN (250 Mg, 2x/day) (View Neutrogin Review and Neutrogin Label ). Patient was hospitalized.

6936214-6 | Convulsion
on Aug 11, 2010 Male patient from KOREA, REPUBLIC OF , 69 years of age, weighting 167.6 lb, was diagnosed with aspergillosis, neutropenia, cough, hepatic candidiasis, febrile neutropenia, vitamin supplementation and was treated with Voriconazole (View Usage). After Voriconazole was administered, patient had the following side effects: convulsion. Voriconazole dosage: 400 Mg, 2x/day. During the same period patient was treated with FILGRASTIM (300 Ug, 1x/day) (View Filgrastim Review and Filgrastim Label ), CODEINE (40 Mg, 3x/day) (View Codeine Review and Codeine Label ), URSODEOXYCHOLIC ACID (200 Mg, 3x/day) (View Ursodeoxycholic Acid Review and Ursodeoxycholic Acid Label ), SILYMARIN (140 Mg, 2x/day) (View Silymarin Review and Silymarin Label ), CEFEPIME (1 G, 1x/day) (View Cefepime Review and Cefepime Label ), IMIPENEM (500 Mg, 2x/day) (View Imipenem Review and Imipenem Label ), ASCORBIC ACID (1 Tablet, 1x/day) (View Ascorbic Acid Review and Ascorbic Acid Label ).

6930976-X | Lymphoma, Respiratory Failure
Patient was taking Voriconazole (View Usage). Patient experienced the following unwanted or unexpected effects: lymphoma (What is lymphoma?), respiratory failure on Jul 13, 2010 from JAPAN Additional patient health information: Male patient , 75 years of age, weighting 94.80 lb, was diagnosed with bronchopulmonary aspergillosis, infection (What is infection?) and. Voriconazole dosage: 300 Mg, 2x/day. During the same period patient was treated with VANCOMYCIN (Unk) (View Vancomycin Review and Vancomycin Label ), GANCICLOVIR (Unk) (View Ganciclovir Review and Ganciclovir Label ), SOLU MEDROL (Unk) (View Solu-medrol Review and Solu-medrol Label ).

6928423-7 | Renal Failure Acute, Respiratory Failure
Adverse event was reported on Aug 05, 2010 by a Male patient taking Voriconazole (View Usage) (Dosage: 300 Mg, 2x/day) was diagnosed with bronchopulmonary aspergillosis and. Location: CHINA , 71 years of age, Patient had the following side effects: renal failure acute, respiratory failure.

6925165-9 | Acute Myeloid Leukaemia, Febrile Neutropenia, Hepatotoxicity, Renal Failure Acute
on Aug 05, 2010 Male patient from KOREA, REPUBLIC OF , 24 years of age, weighting 147.7 lb, was diagnosed with aspergillosis, vomiting, cough, productive cough, neutrophil count decreased, device related infection, blood bilirubin increased and was treated with Voriconazole (View Usage). After Voriconazole was administered, patient had the following side effects: acute myeloid leukaemia, febrile neutropenia, hepatotoxicity, renal failure acute. Voriconazole dosage: 195 Mg, 2x/day. During the same period patient was treated with LORAZEPAM (4 Mg, 1x/day) (View Lorazepam Review and Lorazepam Label ), DIHYDROCODEINE (60 Mg, 2x/day Or 3x/day) (View Dihydrocodeine Review and Dihydrocodeine Label ), IVY EXTRACT (50 Mg, 3x/day) (View Ivy Extract Review and Ivy Extract Label ), LENOGRASTIM (100 Ug, 1x/day) (View Lenograstim Review and Lenograstim Label ), VANCOMYCIN (1 G, 2x/day) (View Vancomycin Review and Vancomycin Label ), URSODEOXYCHOLIC ACID (200 Mg, 3x/day) (View Ursodeoxycholic Acid Review and Ursodeoxycholic Acid Label ). Patient was hospitalized.

6925028-9 | Cerebral Haemorrhage, Hypernatraemia
on Aug 05, 2010 Female patient from KOREA, REPUBLIC OF , 67 years of age, weighting 101.4 lb, was diagnosed with aspergillosis, hypotension, mineral supplementation, infection prophylaxis, convulsion, blood albumin and was treated with Voriconazole (View Usage). Patient experienced the following unwanted or unexpected effects: cerebral haemorrhage, hypernatraemia. Voriconazole dosage: 276 Mg, 2x/day. During the same period patient was treated with RANITIDINE HYDROCHLORIDE (100 Mg, 2x/day) (View Ranitidine Hydrochloride Review and Ranitidine Hydrochloride Label ), DOPAMINE HYDROCHLORIDE (1600 Mg, 1x/day) (View Dopamine Hydrochloride Review and Dopamine Hydrochloride Label ), POTASSIUM CHLORIDE (20- 30 Ml, 1x/day) (View Potassium Chloride Review and Potassium Chloride Label ), CEFTEZOLE SODIUM (2 G, 2x/day) (View Ceftezole Sodium Review and Ceftezole Sodium Label ), VALPROATE SODIUM (500 Mg, 2x/day) (View Valproate Sodium Review and Valproate Sodium Label ), ALBUMIN (HUMAN) (100 Ml, 1x/day) (View Albumin (human) Review and Albumin (human) Label ). Patient was hospitalized.

6923134-6 | Vestibular Disorder
Patient was taking Voriconazole (View Usage). Patient had the following side effects: vestibular disorder on Apr 20, 2010 from TUNISIA Additional patient health information: Male patient , 50 years of age, was diagnosed with meningitis cryptococcal and. Voriconazole dosage: 200 Mg, 2x/day.

6919180-9 | Cardiac Failure
Adverse event was reported on Aug 02, 2010 by a Male patient taking Voriconazole (View Usage) (Dosage: ) . Location: JAPAN , 80 years of age, After Voriconazole was administered, patient had the following side effects: cardiac failure. Patient was hospitalized.

6915625-9 | Neuropathy Peripheral
on May 03, 2010 Male patient from FRANCE , 71 years of age, was diagnosed with bronchopulmonary aspergillosis and was treated with Voriconazole (View Usage). Patient experienced the following unwanted or unexpected effects: neuropathy peripheral. Voriconazole dosage: 400 Mg/ Day. During the same period patient was treated with SIMVASTATIN (20 Mg, Unk) (View Simvastatin Review and Simvastatin Label ), POSACONAZOLE (View Posaconazole Review and Posaconazole Label ).

6914326-0 | Pneumonia, Thrombotic Thrombocytopenic Purpura
on Jul 29, 2010 Female patient from KOREA, REPUBLIC OF , 54 years of age, weighting 114.6 lb, was diagnosed with aspergillosis, thrombotic thrombocytopenic purpura, pneumonia (What is pneumonia?), pain (What is pain?) and was treated with Voriconazole (View Usage). Patient had the following side effects: pneumonia (What is pneumonia?), thrombotic thrombocytopenic purpura. Voriconazole dosage: 300 Mg, 2x/day. During the same period patient was treated with IMMUNOGLOBULINS (5000 Mg, Daily) (View Immunoglobulins Review and Immunoglobulins Label ), MEROPEN (Unk Mg, 3x/day) (View Meropen Review and Meropen Label ), VANCOMYCIN (Unk Mg, 2x/day) (View Vancomycin Review and Vancomycin Label ), CYMEVENE (Unk) (View Cymevene Review and Cymevene Label ), MORPHINE HYDROCHLORIDE (20 Mg, Daily) (View Morphine Hydrochloride Review and Morphine Hydrochloride Label ), RANITIDINE (Unk) (View Ranitidine Review and Ranitidine Label ), ALPROSTADIL (Unk) (View Alprostadil Review and Alprostadil Label ).

6912792-8 | Hallucination
Patient was taking Voriconazole (View Usage). After Voriconazole was administered, patient had the following side effects: hallucination on Dec 23, 2008 from UNITED STATES Additional patient health information: Female patient , child 12 years of age, . Voriconazole dosage: . Patient was hospitalized.

6912168-3 | No Therapeutic Response
Adverse event was reported on Dec 03, 2007 by a Female patient taking Voriconazole (View Usage) (Dosage: ) . Location: UNITED STATES , child 8 years of age, Patient experienced the following unwanted or unexpected effects: no therapeutic response.

6910632-4 | Acute Myeloid Leukaemia, Hepatotoxicity, Nephropathy Toxic, Pneumonia
on Jul 26, 2010 Male patient from KOREA, REPUBLIC OF , 56 years of age, weighting 172.0 lb, was diagnosed with aspergillosis, pneumonia fungal, pyrexia, cough, angina pectoris, hypokalaemia, pancytopenia and was treated with Voriconazole (View Usage). Patient had the following side effects: acute myeloid leukaemia, hepatotoxicity, nephropathy toxic, pneumonia (What is pneumonia?). Voriconazole dosage: 300 Mg, 2x/day. During the same period patient was treated with AMPHOTERICIN B (Unk) (View Amphotericin B Review and Amphotericin B Label ), IMIPENEM AND CILASTATIN SODIUM (750 Mg, 2x/day) (View Imipenem And Cilastatin Sodium Review and Imipenem And Cilastatin Sodium Label ), VANCOMYCIN (550 Mg, 2x/day) (View Vancomycin Review and Vancomycin Label ), ACETAMINOPHEN (650 Mg, 3x/day) (View Acetaminophen Review and Acetaminophen Label ), CODEINE (20 Mg, 3x/day) (View Codeine Review and Codeine Label ), NICORANDIL (5 Mg, 2x/day) (View Nicorandil Review and Nicorandil Label ), K CONTIN CONTINUS (600 Mg, 3x/day) (View K-contin Continus Review and K-contin Continus Label ), LENOGRASTIM (250 Ug, 2x/day) (View Lenograstim Review and Lenograstim Label ). Patient was hospitalized.

6910628-2 | Erythema, Visual Impairment
on Jul 26, 2010 Male patient from CANADA , child 7 years of age, was treated with Voriconazole (View Usage). After Voriconazole was administered, patient had the following side effects: erythema, visual impairment. Voriconazole dosage: Unk. During the same period patient was treated with VITAMIN A (Unk) (View Vitamin A Review and Vitamin A Label ).

6910627-0 | Scotoma, Tunnel Vision, Visual Impairment
Patient was taking Voriconazole (View Usage). Patient experienced the following unwanted or unexpected effects: scotoma, tunnel vision, visual impairment on Jul 26, 2010 from CANADA Additional patient health information: Female patient , 16 years of age, . Voriconazole dosage: Unk. During the same period patient was treated with VITAMIN A (Unk) (View Vitamin A Review and Vitamin A Label ).

6905513-6 | Pneumonitis
Adverse event was reported on Jul 23, 2010 by a Female patient taking Voriconazole (View Usage) (Dosage: 300 Mg, 2x/day) was diagnosed with bronchopulmonary aspergillosis and. Location: SINGAPORE , 45 years of age, weighting 103.6 lb, Patient had the following side effects: pneumonitis. Patient was hospitalized.

6882440-4 | Cardiac Failure
on Jul 14, 2010 Male patient from JAPAN , 80 years of age, was treated with Voriconazole (View Usage). After Voriconazole was administered, patient had the following side effects: cardiac failure. Voriconazole dosage: . Patient was hospitalized.

6818022-X | Constipation, Diarrhoea, Feeling Abnormal, Hypoaesthesia, Neuropathy Peripheral, Therapeutic Response Unexpected, Vomiting
on Jun 18, 2010 Male patient from UNITED KINGDOM , 64 years of age, weighting 235.9 lb, was diagnosed with bronchopulmonary aspergillosis allergic and was treated with Voriconazole (View Usage). Patient experienced the following unwanted or unexpected effects: constipation (What is constipation?), diarrhoea, feeling abnormal, hypoaesthesia, neuropathy peripheral, therapeutic response unexpected, vomiting. Voriconazole dosage: 200 Mg, 2x/day. During the same period patient was treated with CELEBREX (Unk) (View Celebrex Review and Celebrex Label ), TRAMADOL (Unk) (View Tramadol Review and Tramadol Label ), KETOPROFEN (Unk) (View Ketoprofen Review and Ketoprofen Label ).

6817737-7 | Pneumonitis
Patient was taking Voriconazole (View Usage). Patient had the following side effects: pneumonitis on Jun 24, 2010 from SINGAPORE Additional patient health information: Female patient , 45 years of age, weighting 103.6 lb, was diagnosed with bronchopulmonary aspergillosis and. Voriconazole dosage: 300 Mg, 2x/day. Patient was hospitalized.

6817682-7 | Lymphoma, Respiratory Failure
Adverse event was reported on Jun 23, 2010 by a Male patient taking Voriconazole (View Usage) (Dosage: 300 Mg, 2x/day) was diagnosed with bronchopulmonary aspergillosis, infection (What is infection?) and. Location: JAPAN , 75 years of age, weighting 94.80 lb, After Voriconazole was administered, patient had the following side effects: lymphoma (What is lymphoma?), respiratory failure. During the same period patient was treated with VANCOMYCIN (Unk) (View Vancomycin Review and Vancomycin Label ), GANCICLOVIR (Unk) (View Ganciclovir Review and Ganciclovir Label ), SOLU MEDROL (Unk) (View Solu-medrol Review and Solu-medrol Label ).

6803434-0 | Constipation, Diarrhoea, Feeling Abnormal, Hypoaesthesia, Neuropathy Peripheral, Therapeutic Response Unexpected, Vomiting
on Jun 18, 2010 Male patient from UNITED KINGDOM , 64 years of age, weighting 235.9 lb, was diagnosed with bronchopulmonary aspergillosis allergic and was treated with Voriconazole (View Usage). Patient experienced the following unwanted or unexpected effects: constipation (What is constipation?), diarrhoea, feeling abnormal, hypoaesthesia, neuropathy peripheral, therapeutic response unexpected, vomiting. Voriconazole dosage: 200 Mg, 2x/day. During the same period patient was treated with CELEBREX (Unk) (View Celebrex Review and Celebrex Label ), TRAMADOL (Unk) (View Tramadol Review and Tramadol Label ), KETOPROFEN (Unk) (View Ketoprofen Review and Ketoprofen Label ).

6801839-5 | Hydropneumothorax
on Jun 17, 2010 Male patient from KOREA, REPUBLIC OF , 40 years of age, weighting 130.1 lb, was diagnosed with aspergillosis, constipation (What is constipation?), rash (What is rash?) and was treated with Voriconazole (View Usage). Patient had the following side effects: hydropneumothorax. Voriconazole dosage: Unk Mg, 2x/day. During the same period patient was treated with NEUTROGIN (Unk) (View Neutrogin Review and Neutrogin Label ), MEROPEN (Unk) (View Meropen Review and Meropen Label ), VANCOMYCIN (Unk) (View Vancomycin Review and Vancomycin Label ), MAGMIL (Unk) (View Magmil Review and Magmil Label ), HYDROCORTISONE SODIUM SUCCINATE (Unk) (View Hydrocortisone Sodium Succinate Review and Hydrocortisone Sodium Succinate Label ), CANCIDAS (View Cancidas Review and Cancidas Label ), PHENIRAMINE (4 Mg, 1x/day) (View Pheniramine Review and Pheniramine Label ). Patient was hospitalized.

6801718-3 | Pneumonitis
Patient was taking Voriconazole (View Usage). After Voriconazole was administered, patient had the following side effects: pneumonitis on Jun 24, 2010 from SINGAPORE Additional patient health information: Female patient , 45 years of age, weighting 103.6 lb, was diagnosed with bronchopulmonary aspergillosis and. Voriconazole dosage: 300 Mg, 2x/day. Patient was hospitalized.

6801131-9 | Enterococcal Infection, Renal Failure Acute
Adverse event was reported on Jun 17, 2010 by a Female patient taking Voriconazole (View Usage) (Dosage: 360 Mg, 2x/day) was diagnosed with aspergillosis, pneumonia (What is pneumonia?) and. Location: KOREA, REPUBLIC OF , 61 years of age, weighting 133.6 lb, Patient experienced the following unwanted or unexpected effects: enterococcal infection, renal failure acute. During the same period patient was treated with MEROPENEM (View Meropenem Review and Meropenem Label ), VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), LENOGRASTIM (View Lenograstim Review and Lenograstim Label ), REPAGLINIDE (View Repaglinide Review and Repaglinide Label ), PHENIRAMINE (4 Mg, 1x/day) (View Pheniramine Review and Pheniramine Label ), SEPTRIN (1600 Mg, 2x/day) (View Septrin Review and Septrin Label ).

6796212-2 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased
on Jun 24, 2010 Male patient from UNITED STATES , 17 years of age, weighting 88.18 lb, was diagnosed with aspergillosis and was treated with Voriconazole (View Usage). Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased. Voriconazole dosage: 6 Mg/kg Iv Q12. During the same period patient was treated with CYANOCOBALAMIN (View Cyanocobalamin Review and Cyanocobalamin Label ), MEROPENEM (View Meropenem Review and Meropenem Label ), MESALAMINE (View Mesalamine Review and Mesalamine Label ), OSELFAMIVIR (View Oselfamivir Review and Oselfamivir Label ), BACTRIM DS (View Bactrim Ds Review and Bactrim Ds Label ).

6794636-0 | Pneumonia, Sepsis
on Jun 14, 2010 Male patient from KOREA, REPUBLIC OF , 66 years of age, weighting 158.3 lb, was diagnosed with aspergillosis, hypokalaemia, pneumonia (What is pneumonia?), neoplasm malignant and was treated with Voriconazole (View Usage). After Voriconazole was administered, patient had the following side effects: pneumonia (What is pneumonia?), sepsis (What is sepsis?). Voriconazole dosage: 250 Mg, 2x/day. During the same period patient was treated with LOPERAMIDE HYDROCHLORIDE (View Loperamide Hydrochloride Review and Loperamide Hydrochloride Label ), POTASSIUM CHLORIDE (Unk) (View Potassium Chloride Review and Potassium Chloride Label ), VANCOMYCIN (Unk) (View Vancomycin Review and Vancomycin Label ), SEPTRIN (Unk) (View Septrin Review and Septrin Label ), MEROPEN (Unk) (View Meropen Review and Meropen Label ), PHENIRAMINE (4 Mg, 1x/day) (View Pheniramine Review and Pheniramine Label ), LASIX (20 Mg, 1x/day) (View Lasix Review and Lasix Label ), ALKYLOXAN (50 Mg, 1x/day) (View Alkyloxan Review and Alkyloxan Label ).

6794514-7 | Pneumonia, Thrombotic Thrombocytopenic Purpura
Patient was taking Voriconazole (View Usage). Patient experienced the following unwanted or unexpected effects: pneumonia (What is pneumonia?), thrombotic thrombocytopenic purpura on Jun 14, 2010 from KOREA, REPUBLIC OF Additional patient health information: Female patient , 54 years of age, weighting 114.6 lb, was diagnosed with aspergillosis, thrombotic thrombocytopenic purpura, pneumonia (What is pneumonia?), pain (What is pain?) and. Voriconazole dosage: 300 Mg, 2x/day. During the same period patient was treated with IMMUNOGLOBULINS (5000 Mg, Daily) (View Immunoglobulins Review and Immunoglobulins Label ), MEROPEN (Unk Mg, 3x/day) (View Meropen Review and Meropen Label ), VANCOMYCIN (Unk Mg, 2x/day) (View Vancomycin Review and Vancomycin Label ), CYMEVENE (Unk) (View Cymevene Review and Cymevene Label ), MORPHINE HYDROCHLORIDE (20 Mg, Daily) (View Morphine Hydrochloride Review and Morphine Hydrochloride Label ), RANITIDINE (Unk) (View Ranitidine Review and Ranitidine Label ), ALPROSTADIL (Unk) (View Alprostadil Review and Alprostadil Label ).

6783179-6 | Leukaemia
Adverse event was reported on Jun 10, 2010 by a Female patient taking Voriconazole (View Usage) (Dosage: 360 Mg, 2x/day) was diagnosed with fungal infection (What is fungal infection?), pleural disorder (What is pleural disorder?), vitamin supplementation, medical diet and. Location: KOREA, REPUBLIC OF , 60 years of age, weighting 154.3 lb, Patient had the following side effects: leukaemia. During the same period patient was treated with VANCOMYCIN (1000 Mg, 2x/day) (View Vancomycin Review and Vancomycin Label ), MEROPENEM (1000 Mg, 3x/day) (View Meropenem Review and Meropenem Label ), PYRIDOXIN (100 Mg, 2x/day) (View Pyridoxin Review and Pyridoxin Label ), FOLATE (1 Mg, 2x/day) (View Folate Review and Folate Label ), MORPHINE (100 Mg, 1x/day) (View Morphine Review and Morphine Label ), SODIUM CHLORIDE (100 Meq, 1x/day) (View Sodium Chloride Review and Sodium Chloride Label ), COMBIFLEX (1006.5 Ml, 1x/day) (View Combiflex Review and Combiflex Label ).

6770455-6 | Pneumonia
on Jun 03, 2010 Female patient from RUSSIAN FEDERATION , 31 years of age, weighting 136.7 lb, was diagnosed with aspergillosis, pyrexia, mucosal inflammation, antiviral treatment, antifungal treatment and was treated with Voriconazole (View Usage). After Voriconazole was administered, patient had the following side effects: pneumonia (What is pneumonia?). Voriconazole dosage: 268 Mg, 2x/day. During the same period patient was treated with IMIPENEM (2 G, 4x/day) (View Imipenem Review and Imipenem Label ), AMIKACIN (1 G, 1x/day) (View Amikacin Review and Amikacin Label ), VANCOMYCIN (2 G, 2x/day) (View Vancomycin Review and Vancomycin Label ), METRONIDAZOLE (1500 Mg, 3x/day) (View Metronidazole Review and Metronidazole Label ), ZOVIRAX (1250 Mg, 3x/day) (View Zovirax Review and Zovirax Label ), DIFLUCAN (400 Mg, 1x/day) (View Diflucan Review and Diflucan Label ), ZYVOX (1200 Mg, 2x/day) (View Zyvox Review and Zyvox Label ). Patient was hospitalized.

6768494-4 | Acute Myeloid Leukaemia, Hepatotoxicity, Nephropathy Toxic, Pneumonia
on May 31, 2010 Male patient from KOREA, REPUBLIC OF , 56 years of age, weighting 172.0 lb, was diagnosed with aspergillosis, pneumonia fungal, pyrexia, pain (What is pain?), angina pectoris, cough, pancytopenia, hypokalaemia and was treated with Voriconazole (View Usage). Patient experienced the following unwanted or unexpected effects: acute myeloid leukaemia, hepatotoxicity, nephropathy toxic, pneumonia (What is pneumonia?). Voriconazole dosage: 300 Mg, 2x/day. During the same period patient was treated with IMIPENEM (500 Mg, 3x/day) (View Imipenem Review and Imipenem Label ), VANCOMYCIN (1000 Mg, 2x/day) (View Vancomycin Review and Vancomycin Label ), ACETAMINOPHEN (650 Mg, 3x/day) (View Acetaminophen Review and Acetaminophen Label ), NICORANDIL (5 Mg, 2x/day) (View Nicorandil Review and Nicorandil Label ), CODEINE (40 Mg, 3x/day) (View Codeine Review and Codeine Label ), NEUTROGIN (250 Mg, 2x/day) (View Neutrogin Review and Neutrogin Label ), K CONTIN CONTINUS (600 Mg, 3x/day) (View K-contin Continus Review and K-contin Continus Label ). Patient was hospitalized.

6766422-9 | Bronchopulmonary Aspergillosis, Condition Aggravated
Patient was taking Voriconazole (View Usage). Patient had the following side effects: bronchopulmonary aspergillosis, condition aggravated on Jun 07, 2010 from KOREA, REPUBLIC OF Additional patient health information: Male patient , 51 years of age, weighting 141.1 lb, was diagnosed with aspergillosis, liver disorder, hyperplasia, mineral supplementation, gastroduodenal ulcer, antifungal treatment, pyrexia and. Voriconazole dosage: 400 Mg, 2x/day. During the same period patient was treated with URSODIOL (100 Mg, 3x/day) (View Ursodiol Review and Ursodiol Label ), TAMSULOSIN HCL (0.2 Mg, 1x/day) (View Tamsulosin Hcl Review and Tamsulosin Hcl Label ), POTASSIUM CHLORIDE (1200 Mg, 3x/day) (View Potassium Chloride Review and Potassium Chloride Label ), RABEPRAZOLE SODIUM (10 Mg, 1x/day) (View Rabeprazole Sodium Review and Rabeprazole Sodium Label ), ITRACONAZOLE (100 Mg, 2x/day) (View Itraconazole Review and Itraconazole Label ), ZOLPIDEM (10 Mg, 1x/day) (View Zolpidem Review and Zolpidem Label ), ACETAMINOPHEN (Qd) (View Acetaminophen Review and Acetaminophen Label ). Patient was hospitalized.

6763885-X | Convulsion
Adverse event was reported on May 31, 2010 by a Male patient taking Voriconazole (View Usage) (Dosage: 400 Mg, 2x/day) was diagnosed with aspergillosis, neutropenia, cough, hepatic candidiasis, febrile neutropenia, vitamin supplementation and. Location: KOREA, REPUBLIC OF , 69 years of age, weighting 167.6 lb, After Voriconazole was administered, patient had the following side effects: convulsion. During the same period patient was treated with FILGRASTIM (300 Ug, 1x/day) (View Filgrastim Review and Filgrastim Label ), CODEINE (40 Mg, 3x/day) (View Codeine Review and Codeine Label ), URSODEOXYCHOLIC ACID (200 Mg, 3x/day) (View Ursodeoxycholic Acid Review and Ursodeoxycholic Acid Label ), SILYMARIN (140 Mg, 2x/day) (View Silymarin Review and Silymarin Label ), CEFEPIME (1 G, 1x/day) (View Cefepime Review and Cefepime Label ), IMIPENEM (500 Mg, 2x/day) (View Imipenem Review and Imipenem Label ), ASCORBIC ACID (1 Tablet, 1x/day) (View Ascorbic Acid Review and Ascorbic Acid Label ).

6763878-2 | Leukaemia, Neutropenia, No Therapeutic Response
on May 31, 2010 Female patient from KOREA, REPUBLIC OF , 60 years of age, weighting 154.3 lb, was diagnosed with fungal infection (What is fungal infection?), pleural disorder (What is pleural disorder?), vitamin supplementation, medical diet and was treated with Voriconazole (View Usage). Patient experienced the following unwanted or unexpected effects: leukaemia, neutropenia, no therapeutic response. Voriconazole dosage: 360 Mg, 2x/day. During the same period patient was treated with VANCOMYCIN (1000 Mg, 2x/day) (View Vancomycin Review and Vancomycin Label ), MEROPENEM (1000 Mg, 3x/day) (View Meropenem Review and Meropenem Label ), PYRIDOXIN (100 Mg, 2x/day) (View Pyridoxin Review and Pyridoxin Label ), FOLATE (1 Mg, 2x/day) (View Folate Review and Folate Label ), MORPHINE (100 Mg, 1x/day) (View Morphine Review and Morphine Label ), SODIUM CHLORIDE (100 Meq, 1x/day) (View Sodium Chloride Review and Sodium Chloride Label ), COMBIFLEX (1006.5 Ml, 1x/day) (View Combiflex Review and Combiflex Label ).

6762553-8 | Pneumonia
on Jun 03, 2010 Female patient from RUSSIAN FEDERATION , 31 years of age, weighting 136.7 lb, was diagnosed with aspergillosis, pyrexia, mucosal inflammation, antiviral treatment, antifungal treatment and was treated with Voriconazole (View Usage). Patient had the following side effects: pneumonia (What is pneumonia?). Voriconazole dosage: 268 Mg, 2x/day. During the same period patient was treated with IMIPENEM (2 G, 4x/day) (View Imipenem Review and Imipenem Label ), AMIKACIN (1 G, 1x/day) (View Amikacin Review and Amikacin Label ), VANCOMYCIN (2 G, 2x/day) (View Vancomycin Review and Vancomycin Label ), METRONIDAZOLE (1500 Mg, 3x/day) (View Metronidazole Review and Metronidazole Label ), ZOVIRAX (1250 Mg, 3x/day) (View Zovirax Review and Zovirax Label ), DIFLUCAN (400 Mg, 1x/day) (View Diflucan Review and Diflucan Label ), ZYVOX (1200 Mg, 2x/day) (View Zyvox Review and Zyvox Label ). Patient was hospitalized.

6759286-0 | Septic Shock
Patient was taking Voriconazole (View Usage). After Voriconazole was administered, patient had the following side effects: septic shock on May 26, 2010 from KOREA, REPUBLIC OF Additional patient health information: Female patient , 30 years of age, weighting 105.6 lb, was diagnosed with fungal infection (What is fungal infection?) and. Voriconazole dosage: 300 Mg, 2x/day.

6757867-1 | Hepatitis Acute, Mental Status Changes, Renal Failure Acute
Adverse event was reported on Jun 04, 2010 by a Female patient taking Voriconazole (View Usage) (Dosage: 300mg 12 Hours Po) was diagnosed with aspergilloma and. Location: UNITED STATES , 42 years of age, weighting 175.0 lb, Patient experienced the following unwanted or unexpected effects: hepatitis acute, mental status changes, renal failure acute. Patient was hospitalized.

6752262-3 | Photodermatosis, Photosensitivity Reaction
on May 21, 2010 Male patient from UNITED STATES , child 10 years of age, was diagnosed with chronic granulomatous disease, pyrexia and was treated with Voriconazole (View Usage). Patient had the following side effects: photodermatosis, photosensitivity reaction. Voriconazole dosage: Unk. During the same period patient was treated with SULFAMETHOXAZOLE AND TRIMETHOPRIM (Unk) (View Sulfamethoxazole And Trimethoprim Review and Sulfamethoxazole And Trimethoprim Label ), INTERFERON GAMMA 1B (Unk) (View Interferon Gamma-1b Review and Interferon Gamma-1b Label ).

6741682-9 | Zygomycosis
on May 17, 2010 Female patient from BELGIUM , 39 years of age, was diagnosed with fungal infection (What is fungal infection?) and was treated with Voriconazole (View Usage). After Voriconazole was administered, patient had the following side effects: zygomycosis. Voriconazole dosage: .

6704144-0 | Actinic Keratosis, Photosensitivity Reaction, Squamous Cell Carcinoma
Patient was taking Voriconazole (View Usage). Patient experienced the following unwanted or unexpected effects: actinic keratosis, photosensitivity reaction, squamous cell carcinoma on Mar 23, 2010 from FRANCE Additional patient health information: Male patient , 40 years of age, was diagnosed with aspergillosis, immunosuppression and. Voriconazole dosage: Unk. During the same period patient was treated with TACROLIMUS (View Tacrolimus Review and Tacrolimus Label ), MYCOPHENOLATE SODIUM (View Mycophenolate Sodium Review and Mycophenolate Sodium Label ).

6704143-9 | Hyperkeratosis, Skin Lesion, Squamous Cell Carcinoma
Adverse event was reported on Mar 23, 2010 by a Female patient taking Voriconazole (View Usage) (Dosage: Unk) was diagnosed with aspergilloma and. Location: FRANCE , 41 years of age, Patient had the following side effects: hyperkeratosis, skin lesion, squamous cell carcinoma.

6704141-5 | Actinic Keratosis, Photosensitivity Reaction, Squamous Cell Carcinoma
on Mar 23, 2010 Female patient from FRANCE , 24 years of age, was diagnosed with bronchopulmonary aspergillosis and was treated with Voriconazole (View Usage). After Voriconazole was administered, patient had the following side effects: actinic keratosis, photosensitivity reaction, squamous cell carcinoma. Voriconazole dosage: Unk. During the same period patient was treated with TACROLIMUS (View Tacrolimus Review and Tacrolimus Label ), MYCOPHENOLATE SODIUM (View Mycophenolate Sodium Review and Mycophenolate Sodium Label ).

6704103-8 | Actinic Keratosis, Photosensitivity Reaction, Skin Lesion, Squamous Cell Carcinoma
on Mar 23, 2010 Male patient from FRANCE , 53 years of age, was diagnosed with aspergillosis and was treated with Voriconazole (View Usage). Patient experienced the following unwanted or unexpected effects: actinic keratosis, photosensitivity reaction, skin lesion, squamous cell carcinoma. Voriconazole dosage: Unk. During the same period patient was treated with TACROLIMUS (View Tacrolimus Review and Tacrolimus Label ), MYCOPHENOLATE SODIUM (View Mycophenolate Sodium Review and Mycophenolate Sodium Label ).

6686997-8 | Asthenia, Bone Pain, Confusional State, Dizziness, Dysstasia, Gastrointestinal Motility Disorder, Headache, Malaise, Myalgia
Patient was taking Voriconazole (View Usage). Patient had the following side effects: asthenia, bone pain, confusional state, dizziness (What is dizziness?), dysstasia, gastrointestinal motility disorder, headache (What is headache?), malaise, myalgia on Apr 16, 2010 from UNITED STATES Additional patient health information: Male patient , 88 years of age, weighting 152.0 lb, was diagnosed with bronchopulmonary aspergillosis and. Voriconazole dosage: 200 Mg Tablet 1- Twice A Day.